CannTrust (NYSE:CTST) Downgraded to Neutral at Eight Capital

Share on StockTwits

Eight Capital lowered shares of CannTrust (NYSE:CTST) from a buy rating to a neutral rating in a report published on Monday morning, The Fly reports.

CTST has been the topic of a number of other reports. Citigroup set a $95.00 price target on shares of iRobot and gave the stock a hold rating in a report on Wednesday, July 3rd. Bloom Burton upgraded shares of CannTrust from an accumulate rating to a buy rating in a report on Wednesday, May 15th. Zacks Investment Research cut shares of EXACT Sciences from a hold rating to a sell rating in a report on Tuesday, July 2nd. BMO Capital Markets upgraded shares of Tourmaline Oil from a market perform rating to an outperform rating in a report on Thursday, May 30th. Finally, Bank of America restated a sell rating on shares of Deutsche Bank in a report on Monday. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and five have assigned a buy rating to the stock. The stock has an average rating of Buy and an average target price of C$7.94.

NYSE CTST opened at C$3.11 on Monday. The business has a 50-day moving average of C$5.07. The company has a current ratio of 5.64, a quick ratio of 3.38 and a debt-to-equity ratio of 0.01. CannTrust has a 12 month low of C$2.69 and a 12 month high of C$11.97.

CannTrust (NYSE:CTST) last posted its quarterly earnings results on Tuesday, May 14th. The company reported C$0.09 EPS for the quarter, topping the Zacks’ consensus estimate of C($0.05) by C$0.14. The firm had revenue of C$16.85 million for the quarter, compared to analysts’ expectations of C$17.00 million. CannTrust had a negative net margin of 22.33% and a negative return on equity of 6.69%. The business’s revenue for the quarter was up 114.9% on a year-over-year basis. During the same period in the prior year, the business posted $0.12 earnings per share. As a group, equities research analysts anticipate that CannTrust will post -0.03 earnings per share for the current year.

Large investors have recently added to or reduced their stakes in the stock. Davis Rea LTD. purchased a new position in CannTrust in the first quarter valued at about $3,846,000. Legacy Advisors LLC purchased a new stake in shares of CannTrust during the 1st quarter valued at approximately $1,555,000. Virtu Financial LLC purchased a new stake in shares of CannTrust during the 1st quarter valued at approximately $618,000. Paragon Capital Management LLC purchased a new stake in shares of CannTrust during the 1st quarter valued at approximately $54,000. Finally, Winslow Evans & Crocker Inc. purchased a new stake in shares of CannTrust during the 1st quarter valued at approximately $56,000. 5.96% of the stock is owned by institutional investors.

CannTrust Company Profile

CannTrust Holdings Inc produces and sells medical and recreational cannabis in Canada. It sells dried cannabis and cannabis extracts to the medical patients. CannTrust Holdings Inc was incorporated in 2015 and is headquartered in Vaughan, Canada.

Featured Article: What is Call Option Volume?

The Fly

Analyst Recommendations for CannTrust (NYSE:CTST)

Receive News & Ratings for CannTrust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CannTrust and related companies with MarketBeat.com's FREE daily email newsletter.